Also late yesterday, Boston Scientific (BSX) said the U.S. Food and Drug Administration has approved its latest drug-eluting stent, the Promus Element Plus Everolimus-Eluting Platinum Chromium Coronary Stent System.
As chief financial officer and field marshal at hotelier Promus in the 1980s Ledsinger helped make sure every Hampton Inn room looked the same, every mattress felt the same and every bookkeeper counted expenses the same way.